Accelerating Deal Success in Pharma M&A

Join CGI and Life Sciences PA for an exclusive lunch and learn

Pharmaceutical companies are accelerating M&A and licensing activity to rebuild pipelines—but realizing value from these deals depends on how quickly and effectively regulatory content can be integrated.

In this session, we will share how regulatory content migration has become the critical path to post-acquisition success, and how leading organizations are leveraging automation and scalable delivery models to accelerate integration while maintaining compliance.

What you’ll learn

• Why regulatory content migration has become a critical path in pharma M&A integration
• The common challenges across legacy systems, content, data, and global regulatory requirements
• How evolving standards such as eCTD 4.0 and IDMP are shaping migration strategies
• How automation and AI can improve migration speed, quality, and scalability
• Practical approaches for building a more efficient, lower-risk migration model